Notable Guests
OK
Omkar Kawalekar
2x
ZZ
Zoe Zheng
2x
BS
Brian Sullivan
1x
JL
Jeremy Levin
1x
JY
Jhong-Jhe You
1x
KK
Kat Kozyrytska
1x
MW
Matt Winton
1x
AB
Annette Bakker
1x
OG
Oren Gilad
1x
PH
Paul Hastings
1x
SB
Shannon Boye
1x
SG
Sonal Gupta
1x
NC
Nathalie Clement
1x
AB
Aris Baras
1x
Recent Episodes
✨
Brian Sullivan shares Celcuity's first FDA approval for Revtorpyk.
✨
Sonal Gupta discusses engineering regulatory T cells for solid tumors.
✨
Nathalie Clément addresses historical challenges in AAV vector purification.
✨
Paul Hastings discusses building allogeneic CAR NK cell therapies.
✨
Annette Bakker and Andrew Lo discuss rescuing shelved drug candidates.
✨
Shannon Boye details Atsena Therapeutics' gene therapy for Stargardt.
✨
Kat Kozyrytska on technology's role in the biopharma ecosystem.
Kat Kozyrytska
✨
Aris Baras uses human genetics for discovering better drug targets.
✨
Matt Winton discusses late-stage development for dementia treatment.
Matt Winton
How Precision Oncology Is Redefining Cancer Drug Development with Aprea Therapeutics' Dr. Oren Gilad
✨
Oren Gilad explains precision oncology and synthetic lethality.
Oren Gilad
✨
JJ You discusses how antibody design complexity impacts manufacturability.
Jhong-Jhe You
✨
Jeremy Levin addresses public distrust and politicization of science.
✨
Future CGT manufacturing trends include automated platforms and AI.
Omkar Kawalekar
Zoe Zheng
✨
CGT developers need transparency and data visibility from CDMOs.
Omkar Kawalekar
Zoe Zheng